Investigating the antibacterial effects and modes of action of two endophytic fungal extracts from Annona muricata seeds against resistant Staphylococcus aureus

Introduction and objective: Antimicrobial resistance in Staphylococcus aureus represents a major public health concern, highlighting the need for new antibacterial agents. Endophytic fungi associated with medicinal plants are promising sources of bioactive secondary metabolites for this purpose. This study therefore aimed to evaluate the antibacterial activity and investigate the modes of action of two ethyl acetate extracts of endophytic fungi isolated from Annona muricata seeds, against a resistant strain Staphylococcus aureus NR-46003. Methods: The broth microdilution method was used to determine the Minimum Inhibitory Concentrations (MICs) while the effects of the extracts on bacterial growth were assessed by growth kinetics. Additional assays examined cellular protein content, ethidium bromide accumulation, glucose-induced extracellular acidification and antibiofilm activity. Results: Both fungal extracts exhibited pronounced antibacterial potency, with MICs of 25 μg/mL and 12.5 μg/mL for P. citrinum AMs3 and Aspergillus sp. AMs9, respectively. Growth kinetics showed concentration-dependent inhibition, with complete suppression of visible growth at the MIC and higher concentrations over 24 h. Both extracts reduced cellular protein content, increased ethidium bromide retention, and attenuated glucose-induced extracellular acidification, findings consistent with effects on protein biosynthesis, efflux activity and proton transport. Moreover, both extracts demonstrated substantial antibiofilm activity, inhibiting biofilm formation by up to 73.63% and eradicating established biofilms by up to 64.71%. Conclusion: These findings provide compelling evidence supporting the pharmacological exploitation of P. citrinum AMs3 and Aspergillus sp. AMs9 as promising lead candidates for the development of innovative therapeutic interventions against resistant S. aureus infections. Keywords: Antimicrobial resistance, Penicillium citrinum AMs3, Aspergillus sp. AMs9.

Authors

Publication Details

Journal
Journal of Drug Delivery and Therapeutics
Published
2026-11-15
DOI
https://doi.org/10.22270/jddt.v16i11.8088
Primary Topic
Microbial Natural Products and Biosynthesis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Investigating the antibacterial effects and modes of action of two endophytic fungal extracts from Annona muricata seeds against resistant Staphylococcus aureus

Fabrice Fekam Boyom, Victorine Lorette Yimgang, Pierre Michel Jazet Dongmo, Ebenezer Tatiekam Foka et al.
Journal of Drug Delivery and Therapeutics
Microbial Natural Products and Biosynthesis
article

Investigating the antibacterial effects and modes of action of two endophytic fungal extracts from Annona muricata seeds against resistant Staphylococcus aureus

Fabrice Fekam Boyom, Victorine Lorette Yimgang, Pierre Michel Jazet Dongmo, Ebenezer Tatiekam Foka, Brice Rostan Pinlap, Emmanuel Souana
article en

Abstract

Introduction and objective: Antimicrobial resistance in Staphylococcus aureus represents a major public health concern, highlighting the need for new antibacterial agents. Endophytic fungi associated with medicinal plants are promising sources of bioactive secondary metabolites for this purpose. This study therefore aimed to evaluate the antibacterial activity and investigate the modes of action of two ethyl acetate extracts of endophytic fungi isolated from Annona muricata seeds, against a resistant strain Staphylococcus aureus NR-46003. Methods: The broth microdilution method was used to determine the Minimum Inhibitory Concentrations (MICs) while the effects of the extracts on bacterial growth were assessed by growth kinetics. Additional assays examined cellular protein content, ethidium bromide accumulation, glucose-induced extracellular acidification and antibiofilm activity. Results: Both fungal extracts exhibited pronounced antibacterial potency, with MICs of 25 μg/mL and 12.5 μg/mL for P. citrinum AMs3 and Aspergillus sp. AMs9, respectively. Growth kinetics showed concentration-dependent inhibition, with complete suppression of visible growth at the MIC and higher concentrations over 24 h. Both extracts reduced cellular protein content, increased ethidium bromide retention, and attenuated glucose-induced extracellular acidification, findings consistent with effects on protein biosynthesis, efflux activity and proton transport. Moreover, both extracts demonstrated substantial antibiofilm activity, inhibiting biofilm formation by up to 73.63% and eradicating established biofilms by up to 64.71%. Conclusion: These findings provide compelling evidence supporting the pharmacological exploitation of P. citrinum AMs3 and Aspergillus sp. AMs9 as promising lead candidates for the development of innovative therapeutic interventions against resistant S. aureus infections. Keywords: Antimicrobial resistance, Penicillium citrinum AMs3, Aspergillus sp. AMs9.

Journal of Drug Delivery and TherapeuticsVol. 16(11)
Microbial Natural Products and Biosynthesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon